150 related articles for article (PubMed ID: 12088924)
1. The value of plasma markers for the clinical behaviour of phaeochromocytomas.
van der Harst E; de Herder WW; de Krijger RR; Bruining HA; Bonjer HJ; Lamberts SW; van den Meiracker AH; Stijnen TH; Boomsma F
Eur J Endocrinol; 2002 Jul; 147(1):85-94. PubMed ID: 12088924
[TBL] [Abstract][Full Text] [Related]
2. Chromogranin A in familial pheochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution.
Hsiao RJ; Neumann HP; Parmer RJ; Barbosa JA; O'Connor DT
Am J Med; 1990 Jun; 88(6):607-13. PubMed ID: 2189303
[TBL] [Abstract][Full Text] [Related]
3. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
[TBL] [Abstract][Full Text] [Related]
4. Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma.
Stridsberg M; Husebye ES
Eur J Endocrinol; 1997 Jan; 136(1):67-73. PubMed ID: 9037129
[TBL] [Abstract][Full Text] [Related]
5. Adrenal incidentaloma diagnosed as pheochromocytoma by plasma chromogranin A and plasma metanephrines.
Miehle K; Kratzsch J; Lenders JW; Kluge R; Paschke R; Koch CA
J Endocrinol Invest; 2005 Dec; 28(11):1040-2. PubMed ID: 16483187
[No Abstract] [Full Text] [Related]
6. Plasma chromogranin A + B, neuropeptide Y and catecholamines in pheochromocytoma patients.
Gröndal S; Eriksson B; Hamberger B; Theodorsson E
J Intern Med; 1991 May; 229(5):453-6. PubMed ID: 2040871
[TBL] [Abstract][Full Text] [Related]
7. Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning phaeochromocytoma and extra-adrenal paraganglioma.
Kimura N; Miura Y; Nagatsu I; Nagura H
Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):25-32. PubMed ID: 1353277
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma.
Hsiao RJ; Parmer RJ; Takiyyuddin MA; O'Connor DT
Medicine (Baltimore); 1991 Jan; 70(1):33-45. PubMed ID: 1988765
[TBL] [Abstract][Full Text] [Related]
9. Alterations in plasma dopamine-beta-hydroxylase and catecholamine concentrations during surgical removal of pheochromocytoma.
Wocial B; Januszewicz W; Siedlecki I; Feltynowski T; Debiński W
Endokrinologie; 1982 Feb; 79(1):131-9. PubMed ID: 7084126
[TBL] [Abstract][Full Text] [Related]
10. Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment.
Rao F; Keiser HR; O'Connor DT
Hypertension; 2000 Dec; 36(6):1045-52. PubMed ID: 11116123
[TBL] [Abstract][Full Text] [Related]
11. Value of the plasma norepinephrine/3,4-dihydroxyphenylglycol ratio for the diagnosis of pheochromocytoma.
Lenders JW; Willemsen JJ; Beissel T; Kloppenborg PW; Thien T; Benraad TJ
Am J Med; 1992 Feb; 92(2):147-52. PubMed ID: 1543198
[TBL] [Abstract][Full Text] [Related]
12. [Bilateral pheochromocytoma. Is there stimulation of an extra-adrenal adrenaline liberation after bilateral adrenalectomy?].
Schwab KO; Krause M
Monatsschr Kinderheilkd; 1992 Nov; 140(11):828-31. PubMed ID: 1470191
[TBL] [Abstract][Full Text] [Related]
13. Effects of slow-release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma.
Lamarre-Cliche M; Gimenez-Roqueplo AP; Billaud E; Baudin E; Luton JP; Plouin PF
Clin Endocrinol (Oxf); 2002 Nov; 57(5):629-34. PubMed ID: 12390337
[TBL] [Abstract][Full Text] [Related]
14. Plasma catecholamine changes during excision of pheochromocytoma.
Newell KA; Prinz RA; Brooks MH; Glisson SN; Barbato AL; Freeark RJ
Surgery; 1988 Dec; 104(6):1064-73. PubMed ID: 3194833
[TBL] [Abstract][Full Text] [Related]
15. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ
J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032
[TBL] [Abstract][Full Text] [Related]
16. Plasma catecholamine levels in the diagnosis and management of pheochromocytoma.
Hamberger B; Arnér S; Eskilsson P; Lindvall N; Werner S; Granberg PO
Surg Gynecol Obstet; 1981 Mar; 152(3):291-6. PubMed ID: 7466575
[TBL] [Abstract][Full Text] [Related]
17. The use of venous catheterization in the diagnosis and localization of bilateral phaeochromocytomas.
Newbould EC; Ross GA; Dacie JE; Bouloux PM; Besser GM; Grossman A
Clin Endocrinol (Oxf); 1991 Jul; 35(1):55-9. PubMed ID: 1889139
[TBL] [Abstract][Full Text] [Related]
18. Plasma metanephrines in the diagnosis of pheochromocytoma.
Lenders JW; Keiser HR; Goldstein DS; Willemsen JJ; Friberg P; Jacobs MC; Kloppenborg PW; Thien T; Eisenhofer G
Ann Intern Med; 1995 Jul; 123(2):101-9. PubMed ID: 7778821
[TBL] [Abstract][Full Text] [Related]
19. Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases.
Schlumberger M; Gicquel C; Lumbroso J; Tenenbaum F; Comoy E; Bosq J; Fonseca E; Ghillani PP; Aubert B; Travagli JP
J Endocrinol Invest; 1992 Oct; 15(9):631-42. PubMed ID: 1479146
[TBL] [Abstract][Full Text] [Related]
20. Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?
van der Harst E; Bruining HA; Jaap Bonjer H; van der Ham F; Dinjens WN; Lamberts SW; de Herder WW; Koper JW; Stijnen T; Proye C; Lecomte-Houcke M; Bosman FT; de Krijger RR
J Pathol; 2000 Jun; 191(2):175-80. PubMed ID: 10861578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
